These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34913271)

  • 1. Safety and metabolic advantages of steroid withdrawal after 6 months posttransplant in de novo kidney transplantation: A 1-year prospective cohort study.
    Bang JB; Oh CK; Kim YS; Kim SH; Yu HC; Kim CD; Ju MK; So BJ; Lee SH; Han SY; Jung CW; Kim JK; Ahn HJ; Lee SH; Jeon JY
    Immun Inflamm Dis; 2022 Mar; 10(3):e576. PubMed ID: 34913271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion From Steroid to Everolimus in Maintenance Kidney Transplant Recipients With Posttransplant Diabetes Mellitus.
    Nanmoku K; Kurosawa A; Kubo T; Shinzato T; Shimizu T; Kimura T; Yagisawa T
    Exp Clin Transplant; 2019 Feb; 17(1):47-51. PubMed ID: 29911959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-year observational follow-up of a multicenter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant.
    Pascual J; van Hooff JP; Salmela K; Lang P; Rigotti P; Budde K
    Transplantation; 2006 Jul; 82(1):55-61. PubMed ID: 16861942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid-avoidance immunosuppression regimen in live-donor renal allotransplant recipients: a prospective, randomized, controlled study.
    Nematalla AH; Bakr MA; Gheith OA; Elagroudy AE; Elshahawy el-M; Aghoneim M
    Exp Clin Transplant; 2007 Dec; 5(2):673-9. PubMed ID: 18194120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil--a prospective randomized study. Steroid Withdrawal Study Group.
    Ahsan N; Hricik D; Matas A; Rose S; Tomlanovich S; Wilkinson A; Ewell M; McIntosh M; Stablein D; Hodge E
    Transplantation; 1999 Dec; 68(12):1865-74. PubMed ID: 10628766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Freedom from rejection and stable kidney function are excellent criteria for steroid withdrawal in tacrolimus-treated kidney transplant recipients.
    Włodarczyk Z; Wałaszewski J; Perner F; Vitko S; Ostrowski M; Bachleda P; Kokot F; Klinger M; Szenohradsky P; Studenik P; Navratil P; Asztalos L; Rutkowski B; Nagy KK; Hickey D
    Ann Transplant; 2002; 7(3):28-31. PubMed ID: 12465429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 2 Immunosuppression Minimization Strategies in Kidney Transplantation: The ALLEGRO Trial.
    van den Born JC; Meziyerh S; Vart P; Bakker SJL; Berger SP; Florquin S; de Fijter JW; Gomes-Neto AW; Idu MM; Pol RA; Roelen DL; van Sandwijk MS; de Vries DK; de Vries APJ; Bemelman FJ; Sanders JSF
    Transplantation; 2024 Feb; 108(2):556-566. PubMed ID: 37650722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients.
    Phanish MK; Hull RP; Andrews PA; Popoola J; Kingdon EJ; MacPhee IAM;
    BMC Nephrol; 2020 Mar; 21(1):92. PubMed ID: 32160893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: results after four years.
    Höcker B; John U; Plank C; Wühl E; Weber LT; Misselwitz J; Rascher W; Mehls O; Tönshoff B
    Transplantation; 2004 Jul; 78(2):228-34. PubMed ID: 15280683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine.
    Stegall MD; Simon M; Wachs ME; Chan L; Nolan C; Kam I
    Transplantation; 1997 Dec; 64(12):1695-700. PubMed ID: 9422404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year observation of a randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplantation.
    Zhu QG; Zhao YK; Liu W; Luo H; Qiu Y; Gao ZZ
    Chin Med Sci J; 2008 Dec; 23(4):244-8. PubMed ID: 19180887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety and efficacy of early withdrawal of calcineurin inhibitors in kidney transplant recipients 6 months' posttransplant.
    Boswell A; Evans L; Rigg K; Shehata M
    Transplant Proc; 2005 Mar; 37(2):884-5. PubMed ID: 15848564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid avoidance reduce the cost of morbidities after live-donor renal allotransplants: a prospective, randomized, controlled study.
    Gheith OA; Nematalla AH; Bakr MA; Refaie A; Shokeir AA; Ghoneim MA
    Exp Clin Transplant; 2011 Apr; 9(2):121-7. PubMed ID: 21453230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients.
    Kato Y; Tojimbara T; Iwadoh K; Koyama I; Nanmoku K; Kai K; Sannomiya A; Nakajima I; Fuchinoue S; Teraoka S
    Int Immunopharmacol; 2006 Dec; 6(13-14):1984-92. PubMed ID: 17161352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review on steroid withdrawal between 3 and 6 months after kidney transplantation.
    Pascual J; Galeano C; Royuela A; Zamora J
    Transplantation; 2010 Aug; 90(4):343-9. PubMed ID: 20574419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial.
    Thomusch O; Wiesener M; Opgenoorth M; Pascher A; Woitas RP; Witzke O; Jaenigen B; Rentsch M; Wolters H; Rath T; Cingöz T; Benck U; Banas B; Hugo C
    Lancet; 2016 Dec; 388(10063):3006-3016. PubMed ID: 27871759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid withdrawal in renal transplantation.
    Grenda R
    Pediatr Nephrol; 2013 Nov; 28(11):2107-12. PubMed ID: 23288351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of tacrolimus versus cyclosporine in steroid withdrawal in living donor renal transplant recipients.
    Kim SJ; Lee KW; Lee DS; Lee HH; Lee SK; Kim B; Huh WS; Oh HY; Joh JW
    Transplant Proc; 2004 Sep; 36(7):2098-100. PubMed ID: 15518759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective controlled protocol for three months steroid withdrawal with tacrolimus, basiliximab, and mycophenolate mofetil in renal transplant recipients.
    Oh CK; Kim SJ; Kim JH; Lee JH
    J Korean Med Sci; 2012 Apr; 27(4):337-42. PubMed ID: 22468094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.